Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Journal of Experimental & Clinical Cancer Research : CR|October 31, 2019
Impact of Docetaxel on blood-brain barrier function and formation of breast cancer brain metastasesSimon Bernatz, Elena I Ilina, Kavi Devraj, et al.
Breast Cancer Research and Treatment|June 14, 2024
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancerChristian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 1, 2025
National policies for screening and early detection of breast cancer around the globe: Practices, barriers, and solutionsVersha Pleasant, Charulata Bapaye, Femke Delporte, et al.
Patient Safety in Surgery|April 12, 2024
Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot studySvenja Sliwinski, Sara Fatima Faqar-Uz-Zaman, Jan Heil, et al.
European Journal of Cancer (Oxford, England : 1990)|June 29, 2021
Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapyFrederik Marmé, Christine Solbach, Laura Michel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancerCarsten Denkert, Sibylle Loibl, Aurelia Noske, et al.
Geburtshilfe Und Frauenheilkunde|July 2, 2025
Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Geburtshilfe Und Frauenheilkunde|March 16, 2026
Correction: Treatment of Patients with Early Breast Cancer: 19th St. Gallen International Breast Cancer Consensus Discussed against the Background of German Treatment RecommendationsMichael Untch, Maggie Banys-Paluchowski, Sara Y Brucker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2018
Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44)Michael Untch, Gunter von Minckwitz, Bernd Gerber, et al.
Breast Cancer Research and Treatment|June 14, 2011
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40)Gunter von Minckwitz, Silvia Darb-Esfahani, Sibylle Loibl, et al.
Pageof 13